How Is Hepatitis C Detected? Understanding HCV Testing Methods

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV). It spreads mainly through contact with infected blood. Most people feel nothing for years, sometimes decades, while the virus quietly damages the liver.

That silence is the problem. Without testing, many people only find out once scarring, cirrhosis or liver cancer has set in. A hepatitis C test can catch the infection long before that.

But "hepatitis test" can mean more than one thing. There are two main HCV detection methods, and they answer different questions. Here's how each one works.

Why HCV testing matters

The World Health Organization estimates that around 50 million people worldwide live with chronic hepatitis C, and about a million new infections occur each year. A large share of them have never been tested.

The good news is that hepatitis C is curable. Modern antiviral tablets, taken for 8 to 12 weeks, clear the virus in more than 95% of people. Treatment can only start once the infection is found, though, so testing is the first step toward a cure.

HCV detection method 1: antibody testing

When HCV enters the body, the immune system responds by making antibodies against it. The antibody test, often written as anti-HCV, looks for these antibodies in a blood sample. It is usually the first hepatitis C test a person is offered.

Labs run it on automated analysers (ELISA or chemiluminescence methods), and rapid finger-prick versions give a result in under half an hour. It is inexpensive and simple, which makes it well suited to screening large numbers of people.

The antibody test has two limits worth knowing.

• It can't tell past from present. Antibodies usually stay in the blood for life. About a third of people clear the virus on their own within six months, and others are cured with treatment. Both groups still test antibody-positive, even though the virus is gone.

• It can miss a very recent infection. Antibodies take time to appear, usually around 8 to 11 weeks after exposure. A test taken during this window period can come back negative.

So a reactive antibody result means "exposed at some point," not necessarily "infected now."

HCV detection method 2: HCV RNA testing

The HCV RNA test looks for the virus itself rather than the body's response to it. HCV carries its genetic code as RNA.

Using a technique called real-time reverse transcription PCR (RT-PCR), the lab copies tiny amounts of that RNA millions of times until it can be measured. If viral RNA is present, the virus is actively there.

This makes RNA testing the way to confirm a current infection. It can also pick up HCV much earlier than antibody testing, often within one to two weeks of exposure.

RNA tests come in two forms:

1. Qualitative tests answer a yes-or-no question: is HCV RNA detected?
2. Quantitative tests measure how much virus is in the blood, reported as a viral load in international units per millilitre (IU/mL).

Doctors use HCV RNA testing to confirm a reactive antibody result, to test people with weakened immune systems who may not make antibodies reliably, and to check for cure. A sample that shows no detectable RNA 12 weeks after treatment ends means the infection has been cured.

Antibody vs. RNA: how the two tests differ

Antibody test (anti-HCV)

HCV RNA test

What it detects

The immune system's response to HCV

The virus's own genetic material

What a positive result means

Exposed at some point, past or present

Active infection right now

How soon after exposure

Usually 8 to 11 weeks

Often 1 to 2 weeks

Positive after cure?

Yes, usually for life

No

Main role

First-line screening

Confirming infection and checking cure

In practice, the two tests work as a team. The antibody test casts the wide net, and the RNA test settles the question.

A reactive antibody result is never the end of the story: only the RNA test separates a current infection from one that is already gone. Many labs now run the RNA test automatically on the same blood sample when the antibody result is reactive.

This is called reflex testing, and it saves patients a second visit. For people with a recent exposure or a weakened immune system, doctors may order the RNA test straight away.

Getting HCV RNA detection right in the lab

For a lab, the RNA step is where precision matters most. A weak positive sitting near the detection limit, or a sample carrying PCR inhibitors, can delay a report and send a patient back for another blood draw.

NeoDx, a molecular diagnostics company based in Bengaluru, makes a CDSCO-approved hepatitis C real-time PCR detection kit for qualitative detection of the Hepatitis C virus in patient samples. It is designed for routine lab work:

1. A single-tube, MasterMix-ready format, meaning fewer pipetting steps and less risk of cross-contamination.
2. An internal control in the same well, to flag extraction or inhibition problems.
3. Runs on open real-time PCR platforms, including QuantStudio 5, 7500 Fast Dx, CFX96 and Rotor-Gene Q.
4. Limit of detection/Analytical sensitivity: 85 IU/mL, 374 Copies/mL
5. Manufactured in India under ISO 13485:2016, with typical 48-hour dispatch for stocked items.

For in-vitro diagnostic use only.

Who should get a hepatitis C test?

Anyone can ask for one, and testing is especially worth considering if you:

1. received a blood transfusion or organ transplant before blood was routinely screened for HCV
2. have ever injected drugs, even once
3. are on long-term kidney dialysis
4. got a tattoo, piercing or injection with equipment that may not have been sterile
5. are living with HIV
6. were born to a mother with hepatitis C
7. have abnormal liver test results with no clear cause

In India, the National Viral Hepatitis Control Program offers testing and treatment for hepatitis C through government health facilities.

Hepatitis C is one of the few chronic viral infections that can be cured outright. Finding it is the step that makes the cure possible, and for many people a simple blood test is all it takes.